drugset / Trial / NCT03599778
XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To observe and evaluate the efficacy and safety of oxaliplatin with oapecitabine（XELOX）combined with apatinib as post-operative chemotherapy in locally advanced gastric adenocarcinoma with D2 dissection
Timeline
- Start
- 2018-09-01
- Primary completion
- 2025-01-30
- Completion
- 2025-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 250 mg | — |
| Subject | Rivoceranib | Small molecule | 375 mg | — |
| Subject | Rivoceranib | Small molecule | 500 mg | — |